AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PATENT OWNERS & LESSORS
The Joint Corp.
XNAS · usd
SIC 6794 · PATENT OWNERS & LESSORS
FIGI BBG0074VSJK7
7.21▼ 0.17 (-2.24%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
7.37
Day's Range
7.16 – 7.37
52-Week Range
6.79 – 10.70
Volume
35.8K
Avg Volume
84.0K
Share Statistics
Shares Outstanding
Employees
330
Exchange
XNAS
Listed
2014-11-11
Share count as of August 3, 2026

The Joint Corp. (JYNT) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about The Joint Corp. (JYNT)
What is The Joint Corp.'s Market Cap?
The Joint Corp.'s Market Cap is $101.9M, based on as-reported figures from SEC (XBRL) filings.
What is The Joint Corp.'s Trailing P/E?
The Joint Corp.'s Trailing P/E is 26.8×, based on as-reported figures from SEC (XBRL) filings.
What is The Joint Corp.'s Price / Sales?
The Joint Corp.'s Price / Sales is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is The Joint Corp.'s Revenue (TTM)?
The Joint Corp.'s Revenue (TTM) is $58.5M, based on as-reported figures from SEC (XBRL) filings.
What is The Joint Corp.'s Net Income (TTM)?
The Joint Corp.'s Net Income (TTM) is $3.8M, based on as-reported figures from SEC (XBRL) filings.
What is The Joint Corp.'s EBITDA?
The Joint Corp.'s EBITDA is $3.1M, based on as-reported figures from SEC (XBRL) filings.
What is The Joint Corp.'s Diluted EPS (TTM)?
The Joint Corp.'s Diluted EPS (TTM) is 0.27, based on as-reported figures from SEC (XBRL) filings.
What is The Joint Corp.'s EBITDA Margin?
The Joint Corp.'s EBITDA Margin is 5.4%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · JYNTAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues:
Total revenues
YoY growth+14.4%+13.3%+3.1%+5.7%
Cost of revenues:
Cost of revenues————
Total cost of revenues
Selling and marketing expenses
Depreciation and amortization
General and administrative expenses
Total selling, general and administrative expenses
Net loss on disposition or impairment
Net income
% of revenue4.3%8.8%6.5%6.4%
Net income per basic share (in dollars per share)
Net income per diluted share (in dollars per share)